Tag: DOTATOC
![siemens biograph mmr system1](https://www.carcinoid.org/wp-content/uploads/2011/06/siemens-biograph-mmr-system1.jpg)
Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community
June 12, 2011
The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100 abstracts on carcinoid…
READ MORE![Multidisciplinary Team at Bad Berka](https://www.carcinoid.org/wp-content/uploads/2011/04/multidisciplinary-team-at-bad-berka1.jpg)
1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)
April 5, 2011
Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …
READ MORE